4.7 Article

Inverse Susceptibility to Oxidative Death of Lymphocytes Obtained From Alzheimer's Patients and Skin Cancer Survivors: Increased Apoptosis in Alzheimer's and Reduced Necrosis in Cancer

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/gerona/glr258

关键词

Alzheimer; Cancer; Cell death; Apoptosis; Necrosis

资金

  1. Fondecyt Chile [1080569, 1100165, 1110189]
  2. Fondecyt-Fondap [15010006]
  3. Fondecyt [1090071]
  4. National Institute on Aging [P50 AG005681, P01 AG003991, P01 AG026276]
  5. Charles F. and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Center

向作者/读者索取更多资源

A paucity of cancer in individuals with Alzheimer's disease (AD) and low rates of AD in cancer survivors has been reported in epidemiological studies. Deregulation in opposite directions of biological mechanisms, such as susceptibility to cell death, might be shared in the two disorders. We analyzed lymphocytes from AD and skin cancer patients as well as healthy controls and found significantly increased vulnerability of AD lymphocytes to H2O2-induced apoptotic death and higher resistance to death of skin cancer lymphocytes, due to reduced necrosis, as compared with healthy controls by pairwise comparisons adjusted for age and sex. H2O2-induced death in lymphocytes was caspase independent and significantly reduced by PARP-1 inhibition in all three groups. These differences in the susceptibility to cell death observed for lymphocytes from AD and skin cancer patients may be one of the mechanisms that help explain the inverse correlation detected between these diseases in epidemiological studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Geriatrics & Gerontology

Impact of social isolation and coping strategies in older adults with mild cognitive impairment during the covid-19 pandemic: A qualitative study

Maryam Farhang, Claudia Miranda-Castillo, Maria Isabel Behrens, Eduardo Castillo, Sandra Mosquera Amar, Graciela Rojas

Summary: The study found that older adults with mild cognitive impairment (MCI) were mainly psychologically and socially affected by social distancing and isolation during the COVID-19 outbreak, especially those who were alone. They experienced negative emotions such as anger, fear of contracting the virus or passing it to their families, worries, sadness, and emotional loneliness. It is notable that the majority of participants used various coping strategies during this challenging time.

AGING & MENTAL HEALTH (2022)

Article Engineering, Biomedical

Pediatric Extracorporeal Membrane Oxygenation (ECMO) Transport in a Developing Nation: A Single Center Experience

Daniela Martinez, Rodrigo Diaz, Jorge Rufs, Christian Fajardo, Cristian Valverde, Felipe Salech

ASAIO JOURNAL (2022)

Review Psychiatry

Epidemiology of delirium in hospitalized patients in Latin America: A systematic review

Bravo Maximiliano, Bustos Sebastian, Acuna Estefania, Cisternas Irma, Pedro Gutierrez, Ponce de la Vega Daniela P, Castro Roberta, Tobar Eduardo, Maldonado Jose, Salech Felipe

Summary: This study aimed to conduct a systematic analysis of the published data on the epidemiology of delirium in hospitalized patients in Latin America. The study found that delirium occurs frequently in different clinical scenarios, and the occurrence rate varies. The Confusion Assessment Method is the most commonly used delirium assessment tool. However, the implementation of non-pharmacological interventions to prevent delirium is not universal.

ACTA PSYCHIATRICA SCANDINAVICA (2023)

Article Cell Biology

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer's Disease

Sandra Espinoza, Felipe Grunenwald, Wileidy Gomez, Felipe Garcia, Lorena Abarzua-Catalan, Sebastian Oyarce-Pezoa, Maria Fernanda Hernandez, Bastian Cortes, Markus Uhrig, Daniela P. Ponce, Claudia Duran-Aniotz, Claudio Hetz, Carol D. SanMartin, Victor H. Cornejo, Fernando Ezquer, Valentina Parra, Maria Isabel Behrens, Patricio A. Manque, Diego Rojas-Rivera, Rene L. Vidal, Ute Woehlbier, Melissa Nassif

Summary: This study investigated the cell-specific expression of Rubicon in postmortem brain samples from AD patients and 5xFAD mice and its impact on amyloid beta burden. Increased Rubicon levels were found in AD-hiPSCs and postmortem samples. In AD transgenic mice lacking Rubicon, intensified amyloid beta burden was observed. In neuroblastoma cells, the absence of Rubicon led to increased APP/amyloid beta secretion.
Article Clinical Neurology

Biomarkers for dementia in Latin American countries: Gaps and opportunities

Mario A. Parra, Paulina Orellana, Tomas Leon, Cabello G. Victoria, Fernando Henriquez, Rodrigo Gomez, Constanza Avalos, Andres Damian, Andrea Slachevsky, Agustin Ibanez, Henrik Zetterberg, Betty M. Tijms, Jennifer S. Yokoyama, Stefanie D. Pina-Escudero, J. Nicholas Cochran, Diana L. Matallana, Daisy Acosta, Ricardo Allegri, Bianca P. Arias-Suarez, Bernardo Barra, Maria Isabel Behrens, SoniaM. D. Brucki, Geraldo Busatto, Paulo Caramelli, Sheila Castro-Suarez, Valeria Contreras, Nilton Custodio, Sergio Dansilio, Myriam De la Cruz-Puebla, Leonardo Cruz de Souza, Monica M. Diaz, Lissette Duque, Gonzalo A. Farias, Sergio T. Ferreira, Nahuel Magrath Guimet, Ana Kmaid, David Lira, Francisco Lopera, Beatriz Mar Meza, Eliane C. Miotto, Ricardo Nitrini, Alberto Nunez, Santiago O'Neill, John Ochoa, Maritza Pintado-Caipa, Elisa de Paula Franca Resende, Shannon Risacher, Luz Angela Rojas, Valentina Sabaj, Lucas Schilling, Allis F. Sellek, Ana Sosa, Leonel T. Takada, Antonio L. Teixeira, Martha Unaucho-Pilalumbo, Claudia Duran-Aniotz

Summary: Limited knowledge and funding, as well as inadequate infrastructure, present significant barriers to dementia biomarker research in Latin American and Caribbean countries. However, the region shows great potential for advancements in this field.

ALZHEIMERS & DEMENTIA (2023)

Article Biochemistry & Molecular Biology

Senescence Markers in Peripheral Blood Mononuclear Cells in Amnestic Mild Cognitive Impairment and Alzheimer's Disease

Felipe Salech, Carol D. SanMartin, Jorge Concha-Cerda, Esteban Romero-Hernandez, Daniela P. Ponce, Gianella Liabeuf, Nicole K. Rogers, Paola Murgas, Barbara Bruna, Jamileth More, Maria I. Behrens

Summary: Recent studies have shown that cellular senescence is involved in the development of Alzheimer's Disease (AD). By measuring senescence markers in peripheral blood mononuclear cells (PBMCs) of AD patients, this study found that several markers of cellular senescence can be measured in PBMCs of both aMCI and AD patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Environmental Sciences

The Impact of a Yoga-Based Mindfulness Intervention versus Psycho-Educational Session for Older Adults with Mild Cognitive Impairment: The Protocol of a Randomized Controlled Trial

Maryam Farhang, Graciela Rojas, Pablo Martinez, Maria Isabel Behrens, Alvaro Langer, Marcela Diaz, Claudia Miranda-Castillo

Summary: This study aims to evaluate the effectiveness of a yoga-based mindfulness intervention for older adults with MCI and has designed a two-arm individually randomized controlled trial. The results of this study will have significant implications for providing an acceptable and effective non-pharmacological option for MCI in Chile.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Medicine, General & Internal

Non-pharmacological prevention of postoperative delirium by occupational therapy teams: A randomized clinical trial

Evelyn A. Alvarez, Veronica A. Rojas, Lorena I. Caipo, Melany M. Galaz, Daniela P. Ponce, Rodrigo G. Gutierrez, Felipe Salech, Eduardo Tobar, Fernando I. Reyes, Rodrigo C. Vergara, Jose I. Egana, Constanza A. Briceno, Antonello Penna

Summary: Patients who develop postoperative delirium (POD) have several clinical complications, such as increased morbidity, increased hospital stays, higher hospital costs, cognitive and functional impairment, and higher mortality. A prospective clinical study was conducted to determine whether patients undergoing intervention by an Occupational Therapy (OT) team have a lower incidence of POD compared to the group treated only with standard measures.

FRONTIERS IN MEDICINE (2023)

Article Clinical Neurology

A call for clinical trial globalization in Alzheimer's disease and related dementia

Jorge J. Llibre-Guerra, Anika Heavener, Sonia Maria Dozzi Brucki, Juan Pablo Diaz Marante, Maritza Pintado-Caipa, Yaohua Chen, Maria Isabel Behrens, Angela Hardi, Arianna Admirall-Sanchez, Rufus Akinyemi, Suvarna Alladi, Karen A. Dorsman, Ana M. Rodriguez-Salgado, Joel Solorzano, Ganesh M. Babulal

Summary: The burden of Alzheimer's disease and related dementia (ADRD) is projected to be disproportionally higher in low-middle-income countries (LMICs). However, there is a lack of representation of LMICs in ADRD clinical trial platforms. This study found that only 11.6% of ADRD clinical trials were conducted in emerging economies (upper-middle income [9.6%] and low-middle income [2.0%]). The limitations for trial implementation in LMICs include limited financial resources, low industry presence, regulatory obstacles, and operational barriers.

ALZHEIMERS & DEMENTIA (2023)

Article Geriatrics & Gerontology

Visual-spatial processing impairment in the occipital-frontal connectivity network at early stages of Alzheimer's disease

Ivan Plaza-Rosales, Enzo Brunetti, Rodrigo Montefusco-Siegmund, Samuel Madariaga, Rodrigo Hafelin, Daniela P. Ponce, Maria Isabel Behrens, Pedro E. Maldonado, Andrea Paula-Lima

Summary: This study evaluated the manifestations and mechanisms of visual-spatial deficits in early stages of Alzheimer's disease (AD) using behavioral, electroencephalography (EEG), and eye movement recordings. The results showed impaired spatial learning and altered visual exploration in AD patients, suggesting early and specific features for understanding functional connectivity loss. These findings are clinically promising for early diagnosis and improving quality of life of AD patients.

FRONTIERS IN AGING NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients

Carol D. SanMartin, Felipe Salech, Daniela Paz Ponce, Jorge Concha-Cerda, Esteban Romero-Hernandez, Gianella Liabeuf, Nicole K. Rogers, Paola Murgas, Barbara Bruna, Jamileth More, Maria I. Behrens

Summary: Epidemiological studies find that having a history of cancer or Alzheimer's Disease (AD) can protect against the development of the other. The underlying mechanism for this mutual protection is unknown. However, research suggests that PBMCs of individuals with aMCI and AD have increased susceptibility to oxidative cell death, while a history of cancer is associated with increased resistance to cell death caused by oxidative stress.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Health Care Sciences & Services

Classification of Alzheimer's disease and frontotemporal dementia using routine clinical and cognitive measures across multicentric underrepresented samples: A cross sectional observational study

Marcelo Adrian Maito, Hernando Santamaria-Garcia, Sebastian Moguilner, Katherine L. Possin, Maria E. Godoy, Jose Alberto Avila-Funes, Maria Behrens, Ignacio L. Brusco, Martin A. Bruno, Juan F. Cardona, Nilton Custodio, Adolfo M. Garcia, Shireen Javandel, Francisco Lopera, Diana L. Matallana, Bruce Miller, Maira Okada de Oliveira, Stefanie D. Pina-Escudero, Andrea Slachevsky, Ana L. Sosa Ortiz, Leonel T. Takada, Enzo Tagliazuchi, Victor Valcour, Jennifer S. Yokoyama, Agustin Ibanez

Summary: This study aimed to discriminate between Alzheimer's disease (AD) and frontotemporal dementia (FTD) using demographic, clinical, and cognitive data. Results showed that a machine learning model achieved accurate classification of patients, indicating that data-driven techniques can enhance diagnostic procedures in resource-limited regions. The study also highlighted the potential of specific cognitive and behavioral measures for the diagnosis of AD and FTD in Latin American countries.

LANCET REGIONAL HEALTH-AMERICAS (2023)

Article Clinical Neurology

Biomarkers for dementia in Latin American countries: Gaps and opportunities

Mario A. Parra, Paulina Orellana, Tomas Leon, Cabello G. Victoria, Fernando Henriquez, Rodrigo Gomez, Constanza Avalos, Andres Damian, Andrea Slachevsky, Agustin Ibanez, Henrik Zetterberg, Betty M. Tijms, Jennifer S. Yokoyama, Stefanie D. Pina-Escudero, J. Nicholas Cochran, Diana L. Matallana, Daisy Acosta, Ricardo Allegri, Bianca P. Arias-Suarez, Bernardo Barra, Maria Isabel Behrens, SoniaM. D. Brucki, Geraldo Busatto, Paulo Caramelli, Sheila Castro-Suarez, Valeria Contreras, Nilton Custodio, Sergio Dansilio, Myriam De la Cruz-Puebla, Leonardo Cruz de Souza, Monica M. Diaz, Lissette Duque, Gonzalo A. Farias, Sergio T. Ferreira, Nahuel Magrath Guimet, Ana Kmaid, David Lira, Francisco Lopera, Beatriz Mar Meza, Eliane C. Miotto, Ricardo Nitrini, Alberto Nunez, Santiago O'Neill, John Ochoa, Maritza Pintado-Caipa, Elisa de Paula Franca Resende, Shannon Risacher, Luz Angela Rojas, Valentina Sabaj, Lucas Schilling, Allis F. Sellek, Ana Sosa, Leonel T. Takada, Antonio L. Teixeira, Martha Unaucho-Pilalumbo, Claudia Duran-Aniotz

Summary: Limited knowledge on dementia biomarkers in Latin American and Caribbean countries due to lack of funding, infrastructure, and training. However, the region holds great potential to advance dementia biomarkers research and it is crucial to expand research in this field.

ALZHEIMERS & DEMENTIA (2023)

Review Geriatrics & Gerontology

The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review

Hong Lin, Felipe Salech, Anthony Lim, Sara Vogrin, Gustavo Duque

Summary: This systematic review evaluated the efficacy of rapalogues in age-related musculoskeletal disorders (MSKD) in humans. While some studies have assessed the effects of rapamycin and rapalogues on bone, muscle, and joints, there is considerable variability in subjects' age, inclusion criteria, and drug administration protocols. The evidence supporting their use is still limited, and further research is needed to explore the clinical implications on osteoporosis, sarcopenia, or osteosarcopenia.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

暂无数据